Pergolide Treatment and Valvular Heart Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
In a blinded echocardiographic study we investigate the frequency of valvular abnormalities in a group of Parkinson patients treated with either ergot derived dopamine agonists (pergolide and cabergoline) or non-ergot derived dopamine agonists (pramipexole and ropinirole). The ability to detect patients with valvular abnormalities by clinical approach is examined.
Epistemonikos ID: 3182d3b168890fb119dcdffec4612d2aac79b43b
First added on: May 04, 2024